de la Torre, R., de Sola, S., Hernandez, G., Farré, M., Pujol, J., Rodriguez, J., . . . Dierssen, M. (2016). Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial. Lancet neurology, 15(8), 801-810. https://doi.org/10.1016/S1474-4422(16)30034-5
Chicago-Zitierstil (17. Ausg.)de la Torre, Rafael, et al. "Safety and Efficacy of Cognitive Training Plus Epigallocatechin-3-gallate in Young Adults with Down's Syndrome (TESDAD): A Double-blind, Randomised, Placebo-controlled, Phase 2 Trial." Lancet Neurology 15, no. 8 (2016): 801-810. https://doi.org/10.1016/S1474-4422(16)30034-5.
MLA-Zitierstil (9. Ausg.)de la Torre, Rafael, et al. "Safety and Efficacy of Cognitive Training Plus Epigallocatechin-3-gallate in Young Adults with Down's Syndrome (TESDAD): A Double-blind, Randomised, Placebo-controlled, Phase 2 Trial." Lancet Neurology, vol. 15, no. 8, 2016, pp. 801-810, https://doi.org/10.1016/S1474-4422(16)30034-5.